LS ARK Genomic Revolution Tracker ETP Securities
|
|
|
|
ISIN: XS2399368062
Nettoinventarwert (NAV)
| 2,33 USD | 0,04 USD | 1,71 % |
|---|
| Vortag | 2,29 USD | Datum | 10.11.2025 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
LS ARK Genomic Revolution Tracker ETP Securities aktueller Kurs
| 1,90 EUR | -0,09 EUR | -4,45 % |
|---|
| Datum | 13.11.2025 20:10:26 |
| Vortag | 1,99 EUR |
| Börse | Düsseldorf |
Rating für LS ARK Genomic Revolution Tracker ETP Securities
| €uro FondsNote | - |
Fonds Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 5,87 | |
| Performance 2 Jahre | 18,62 | |
| Performance 3 Jahre | -21,45 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
Fundamentaldaten
| WKN | |
| ISIN | XS2399368062 |
| Name | LS ARK Genomic Revolution Tracker ETP Securities |
| Fondsgesellschaft | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 952 675,33 |
| Depotbank | |
| Zahlstelle | |
| Fondsmanager | |
| Geschäftsjahresende | |
| Berichtsstand | 12.11.2025 |
Konditionen
| Ausgabeaufschlag | % |
| Verwaltungsgebühr | % |
| Depotbankgebühr | % |
| VL-fähig? | Nein |
| Mindestanlage | |
| Ausschüttung | Thesaurierend |